We are a fully integrated, pure-play biologics Contract Development and Manufacturing Organization (CDMO), capable of converting drug substances into stable formulations and fill and finish formats. We provide the full range of services, from cell line technology transfer to clinical and commercial manufacturing. We offer world-class cGMP production facilities, established technical proficiency in microbial, mammalian, viral, and other technological platforms, and high-quality services for your international initiatives. Contemporary Facilities We host process development laboratories, scale-up, and manufacturing areas for mammalian, microbial, and other modalities in our three cutting-edge buildings, which total about 85,000 square metres in area. For products based on monoclonal antibodies, fusion proteins, conjugation factors, vaccines, cell-free protein expression platforms, DNA adjuvants/plasmids, RNA products, cell and gene therapies, our highly automated facilities offer global services.